Phase 1b of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC) Meeting Abstract

  

Authors:	Spigel, D. R.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Kapoun, A.; Xu, L.; Hill, D.; Zhou, L.; Dupont, J.; Pietanza, M. C.
Abstract Title:	Phase 1b of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613204059
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.7601
Notes:	Meeting Abstract: 7601 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/81064